Swarupa Kancherla is an Ophthalmology physician affiliated with Johns Hopkins University. OpenAlex indexes 19 publications with 371 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Baltimore, MD 212870005
Telephone
410-955-5214Registry record last updated 29 Jun 2018.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year20257 payments
- Tarsus Pharmaceuticals, Inc.Program year202510 payments
- Dompe US, Inc.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
59.6%Corticosteroid22.6%Prednisolone Acetate100%Part D≥92 patientsProstaglandin Analog15.4%Latanoprost87%Lumigan13%Part D<11 patients+ 6 more classes in this area
Anti-infectives
22%Macrolide11.2%Erythromycin100%Part D≥54 patientsFluoroquinolone Antibacterial8.7%Moxifloxacin100%Part D≥28 patients+ 1 more class in this area
Cancer & immunology
11.9%Calcineurin inhibitor11.9%Restasis65%Cyclosporine20%Cequa15%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Descemet membrane endothelial keratoplasty in eyes with COL8A2-associated corneal dystrophy
American Journal of Ophthalmology Case Reports
2022 - In vivo MRI evaluation of early postnatal development in normal and impaired rat eyes
Scientific Reports
2021 - CLOSTRIDIUM PERFRINGENS PANOPHTHALMITIS AFTER INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION
Retinal Cases & Brief Reports
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Laheru, MD
Johns Hopkins University
Demosthenes G. Katritsis
Johns Hopkins University
Tanguy Seiwert, MD
Johns Hopkins University
Evan Lipson, MD
Johns Hopkins University
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”